Isolation of Legionella longbeachae Serogroup 1 from Potting Soils in Japan
Legionella longbeachae is the major causative agent of legionnaires' disease in Australia, which is considered by many to be the result of use of potting soil containing the bacterium. Australian potting soil is not sterilized during manufacture and contains a complex mixture of bacteria and free-living amebae [1] . Elevated storage temperatures appear to foster the intraamebic growth of L. longbeachae in potting soil [2] . We report the first cultureproven case of L. longbeachae pneumonia in Japan and the results of a survey of Japanese potting soil for the bacterium.
A 52-year-old gardener who had recently traveled to Guam was admitted to a Japanese clinic because of fever, cough, and dyspnea in 1996. L. longbeachae serogroup 1 was isolated from his sputum. He died of pneumonia despite treatment with multiple antibiotics including erythromycin. One-half year later, potting soil was sampled from the company where the patient had worked. Legionella bozemanii and Legionella spiritensis, but not L. longbeachae, were isolated from this sample.
In 1998, we surveyed 17 other Japanese potting soils for the presence of Legionella species by using a variety of selective media and amebic enrichment techniques. The soils were purchased from stores in Hyogo, Nagasaki, and Okinawa between January and September 1998. The potting soils were ready-to-use products, of which nine contained composted wood products and Table 1 . Isolation of Legionella species from 17 Japanese potting soils.
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Disseminated Acanthamoeba Infection in a Patient with AIDS: Response to 5-Fluorocytosine Therapy
Free-living amebas belonging to the genera Naegleria, Acanthamoeba, and Balamuthia are pathogenic protozoa for humans and animals. Acanthamoeba species and Balamuthia mandrillaris are opportunistic pathogens that cause infections involving preferentially the skin, sinuses, and CNS (granulomatous amebic encephalitis) [1] . These infections occur mainly in immunocompromised patients, particularly those with advanced HIV infection. This report describes a patient with AIDS who had cutaneous and sinus infections due to Acanthamoeba. The original aspect was a protracted clinical course related to medical treatment.
A 29-year-old woman was found to be seropositive for HIV type 1 (via heterosexual transmission) in 1992. Between 1992 and 1995, her medical history included oral candidiasis, pulmonary tuberculosis, herpes zoster, B cell non-Hodgkin's lymphoma of a tonsil, tonsillar actinomycosis, and chronic sinusitis with recurrent epistaxis. In June 1995, 3 months after a trip to Thailand, she developed three cutaneous nodules on the left thigh without fever or weight loss (her weight, 50 kg). Therapy at that time included zidovudine (400 mg/d) and trimethoprim-sulfamethoxazole (80/400 mg/d). One month later, new skin lesions (painful, nontender, erythematous, purplish papules and nodules ranging from a few millimeters to several centimeters in diameter) appeared on all four extremities. Some of the lesions became ulcerated and crusted (figure 1). Differential diagnosis included cryptococcal dermatitis and Penicillium marneffei infection.
Laboratory studies showed a WBC count of 2.9 ϫ 10 9 /L and a CD4 cell count of 2 ϫ 10 6 /L. No microorganisms were observed in cultures of blood, urine, and smear of a skin ulcer. A biopsy specimen from the cutaneous nodule was stained with periodic acid-Schiff and hematoxylin-eosin stains. Examination revealed a polymorphous inflammatory infiltrate and necrotizing vasculitis. A multinucleated giant cell was noted (unpublished data, A. J. Martinez). Some round structures were observed with a dense central nucleolus, a less dense nucleus, and a thick, well-stained wall. The presence of trophozoites and cysts of free-living amebas was suggested.
Cultures of skin biopsy samples inoculated on nonnutriment agar plates coated with Escherichia coli yielded marked growth of free-living amebas, both trophozoite and cyst forms. Immunofluorescence testing of the skin biopsy samples confirmed the presence of free-living amebas of the genus Acanthamoeba (unpublished data, G. S. Visvesvara). MRI of the head showed pansinusitis. CSF examination revealed a protein level of 0.83 g/L.
Treatment was started in August 1995 with the combination of 5-fluorocytosine (7.5 g/d intravenously) and itraconazole (400 mg/d orally). Marked improvement in the skin lesions was noted from the first week of treatment. On the 15th day of treatment, 5-fluorocytosine was discontinued because of hematologic toxicity. After 13 days of monotherapy with itraconazole, new skin nodules and ulcers appeared. Administration of 5-fluorocytosine
